Bienstar Wellness

Bienstar Wellness, through its Brazilian clinics, Clínicas Beneva, will begin offering ibogaine treatments for addiction in Curitiba, the capital of the Paraná province in Brazil, starting in March. With a population of two million people, Curitiba is the largest city in the southern...

By Franca Quarneti, via El Planteo "Latin America is so ready for psychedelics: the fourth country in the world with the most scientific publications on psychedelics, after the United States, Canada, and the United Kingdom, is Brazil." Thus began Marco Algorta's presentation at Latam...

Zinger Brief Dr. Dartiu da Silveira is a renowned Brazilian psychiatrist and a pioneer in psychedelics scientific research. Dr. Silveira will collaborate with Bienstar as a scientific advisor. The advisor will focus on ibogaine assisted therapies protocols, medical education programs and clinical...

Zinger Brief The acquisition of BRC Saude Mental & Terapias Assistidas Ltda. provides Bienstar access to the Brazilian market, the largest in Latin America, with a population of 215 million. Ketamine and ibogaine substances are regulated for medical use in Brazil. BRC conducts legal ibogaine...

It’s earnings week in the psychedelics space, opening a new window into the financial situations of many companies in the sector. Atai, MindMed, Enveric, Mydecine and Filament Health all released their numbers for 2021, with positions varying between “very well-capitalized” to...

Bienstar Wellness Corp., an integrative mental health company specializing in psychedelic medicine with core operations in Latin America, has entered into a binding letter of intent to acquire 100% of BRC Saude Mental E Terapias Assistidas Ltda., a Brazilian psychedelic institution specialized in...